OSI Pharmaceuticals (OSIP) - formerly Oncogene Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: fred hayes	11/10/2005 12:35:34 PM
	Read Replies (2) of 447

Here we go. OSIP halted. BD making noise about reviewing EYET transaction. I think the deal will be called off... fred hayes add/edit: from Reuters re EYET shareholders meeting where sale was approved today by EYET shareholders... ------------ *** Earlier this week, Genentech announced positive data from a late-stage trial of its drug, Lucentis, and said it will apply to the U.S. Food and Drug Administration next month. Eyetech on Thursday said OSI's board wants time to assess the possible impact of Genentech's announcement, but added that OSI has not yet said it will not close the deal. snip...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next